Vascular Solutions, Inc.  

(Public, NASDAQ:VASC)   Watch this stock  
Find more results for CHARMAINE WILLIAMS�
24.53
-0.02 (-0.08%)
Real-time:   9:50AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 24.53 - 24.95
52 week 15.60 - 28.21
Open 24.57
Vol / Avg. 1,811.00/65,168.00
Mkt cap 421.47M
P/E 34.97
Div/yield     -
EPS 0.70
Shares 17.18M
Beta 0.09
Inst. own 59%
Nov 18, 2014
Vascular Solutions Inc at Stifel Healthcare Conference Add to calendar
Oct 20, 2014
Q3 2014 Vascular Solutions Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Aug 14, 2014
Vascular Solutions Inc at Canaccord Genuity Growth Conference
Aug 6, 2014
Vascular Solutions Inc at CFA Society of Minnesota's InvestMNt Conference
Jul 22, 2014
Q2 2014 Vascular Solutions Inc Earnings Call
Jul 22, 2014
Q2 2014 Vascular Solutions, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 10.45% 10.08%
Operating margin 16.40% 14.57%
EBITD margin - 19.78%
Return on average assets 11.15% 11.36%
Return on average equity 12.60% 12.86%
Employees 406 -
CDP Score - -

Address

6464 SYCAMORE COURT NORTH
MINNEAPOLIS, MN 55369
United States - Map
+1-763-6564300 (Phone)
+1-877-6564251 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Vascular Solutions, Inc. (Vascular) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists. Vascular offers product and service in three categories: catheter products, hemostat products and vein products and services. Catheter products consist of catheters used in minimally invasive medical procedures for the diagnosis or treatment of vascular conditions. Hemostat (blood clotting) products consist of the D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding, and the D-Stat Flowable. Vein products consist of the Vari-Lase endovenous laser. In December 2011, it acquired 5-year rights to sell reprocessing services for the ClosureFast catheter in the United States from Northeast Scientific, Inc. In June 2012, the Company acquired the radial artery access wrist positioning splint product assets of Accumed Systems, Inc.

Officers and directors

John L. Erb Independent Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Howard Root Chief Executive Officer and Director
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James Hennen Chief Financial Officer, Senior Vice President - Finance, Corporate Secretary
Age: 40
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William Rutstein Senior Vice President - Worldwide Sales
Age: 61
Bio & Compensation  - Reuters
Charmaine Sutton Senior Vice President - Operations
Age: 54
Bio & Compensation  - Reuters
Susan Christian Vice President - Sales Operations
Age: 45
Bio & Compensation  - Reuters
Carrie Powers Vice President - Marketing
Age: 39
Bio & Compensation  - Reuters
Phillip E. Nalbone Vice President - Corporate Development
Age: 52
Bio & Compensation  - Reuters
Brett Demchuk Vice President - Product Quality
Age: 49
Bio & Compensation  - Reuters
Jonathan M. Hammond Vice President - Manufacturing Engineering
Age: 46
Bio & Compensation  - Reuters